Skip to main content
Normal View

Vaccination Programme.

Dáil Éireann Debate, Tuesday - 20 October 2009

Tuesday, 20 October 2009

Questions (159)

James Reilly

Question:

247 Deputy James Reilly asked the Minister for Health and Children if she will give a commitment to allocate and include funds for a national cervical vaccination programme in 2010. [36665/09]

View answer

Written answers

I have considered all the relevant advice available to me in relation to the potential public health benefits of HPV vaccination in the prevention of cervical cancer and the wider policy implications for its possible introduction into the National Immunisation Programme. I accept the consensus view of the relevant expert bodies that the introduction of a universal high uptake vaccination programme in young girls, in conjunction with population based cervical screening, could significantly reduce overall cervical cancer incidence. All of the clinical advice available to me indicates that, in the context of the limited resources available, the national roll-out of a cervical screening programme should take precedence over the introduction of a HPV vaccination programme.

The Health Information and Quality Authority (HIQA) has completed an assessment of the cost effectiveness of HPV. It shows that the vaccine does have the potential to play an important long term role in the prevention of cervical cancer and that a vaccination programme should be put in place to enable these long term benefits to be realised.

Accordingly, in August 2008, the Health Service Executive (HSE) was requested by the Department to examine operational and procurement issues relating to the introduction of a HPV vaccination programme for 12 year old girls on a basis that would achieve maximum cost effectiveness and appropriate national uptake rates.

I am keeping the cost of implementing such a programme under review. I am committed to progressively introducing cancer prevention measures, such as new screening and vaccination programmes, according to clinical prioritisation within the resources available in 2010 and beyond.

Top
Share